| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c16667a3d016a525f0f8723230e403ad |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-207 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-207
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-256 |
| filingDate |
2001-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a1fa03f72f3a75314114eb726b8cceb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1470b0b47db61f3671e69b021dfb786f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_160b5784abe91c57a95f205a1073d0a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d57b3ae5423e970899d5cb086d28f502 |
| publicationDate |
2001-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2433854-A1 |
| titleOfInvention |
Inositol phosphoglycan derivatives and their medical uses |
| abstract |
Compounds having a mimetic or antagonistic property of an inositol phosphoglycan, and the uses of these compounds are disclosed, together with the use, e.g. to treat a condition ameliorated by administration of an IPG second messenger or an IPG antagonist thereof. Preferred compounds of the invention are based on the substituted cyclitols, and in particular cyclitols linked to a sugar moiety where the molecule is substituted with a negatively charged group such as phosphate. |
| priorityDate |
2000-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |